Abrupt and brief discontinuation of antidepressant treatment: Effects on cognitive function and psychomotor performance

International Clinical Psychopharmacology

Volumn 15, Issue 6, 2000, Pages 305-318

  Hindmarch, I ^a   Kimber, S ^a   Cockle, S M ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Cognition; Depression; Discontinuation syndrome; Psychomotor performance; Selective serotonin reuptake inhibitors (SSRIs)

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SLEEP; WITHDRAWAL SYNDROME;

EID: 0033764960     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015060-00001     Document Type: Article

References (35)

1. The effects of paroxetine and dothiepin on psychomotor performance, cognitive function and sleep in depressed patients
2. Tofranil treatment of endogenous depressions
3. Citalopram withdrawal symptoms
4. The abrupt discontinuation of fluvoxamine in patients with panic disorder
5. The Cognitive Failures Questionnaire (CFQ) and its correlates
6. Serotonin reuptake inhibitor withdrawal
7. Compliance with medication regimens for mental and physical disorders
8. Compliance in depressed patients treated with fluoxetine and amitriptyline
9. Withdrawal phenomena associated with antidepressant and anti-psychotic agents
10. Antidepressant withdrawal phenomena
11. Citalopram compared to dothiepin and placebo: Effects of cognitive function and psychomotor performance
12. The effects of fluoxetine and dothiepin on cognitive function in depressed patients in general practice
13. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine
14. A 1-4 Benzodiazepine, temazepam (K3917), effect on some psychological parameters of sleep and behaviour
15. Psychomotor function and psychoactive drugs
16. Critical Flicker Fusion Frequency (CFF): The effects of psychotropic compounds
17. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability
18. The effects of sertraline on psychomotor performance in elderly volunteers
19. Comparison of five anxiolytic benzodiazepines on measures of psychomotor performance and sleep
20. Gaps in anti-depressant prescribing in primary care in the United Kingdom
21. The effects of fluoxetine on psychomotor performance, cognitive function and sleep in depressed patients
22. The effects of paroxetine and dothiepin on subjective sleep in depressed patients
23. Antidepressant withdrawal syndrome: Recognition, prevention, and management
24. Interruption of selective serotonin reuptake inhibitor treatment
25. A new depression scale designed to be sensitive to change
26. Discontinuation syndromes with selective serotonin reuptake inhibitors. Are there clinically relevant differences?
27. Factor analysis of a sleep evaluation questionnaire
28. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal
29. Selective serotonin re-uptake inhibitor discontinuation syndrome: A randomised clinical trial
30. The reliability, validity and pharmacosensitivity of four psychomotor tests
31. Selective serotonin reuptake inhibitors and withdrawal symptoms: A review of the literature
32. Role of patient compliance in clinical pharmacokinetics. A review of recent research
33. A self-rating depression scale